Loading…
Greenwich LifeSciences, Inc. is projected to rise to $27.65 by 2027, a +40% move from its current price of $19.80. GLSI is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $18.80 | $19.80 | $20.85 | -0.02% |
| Jul 14 | $18.40 | $19.79 | $21.29 | -0.03% |
| Jul 15 | $18.10 | $19.79 | $21.64 | -0.05% |
| Jul 16 | $17.85 | $19.79 | $21.94 | -0.06% |
| Jul 17 | $17.63 | $19.78 | $22.20 | -0.08% |
| Jul 18 | $17.43 | $19.78 | $22.45 | -0.09% |
| Jul 19 | $17.25 | $19.78 | $22.67 | -0.11% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $17.25 | $19.78 | $22.67 | -0.11% |
| Week 2 | $16.29 | $19.76 | $23.96 | -0.22% |
| Week 3 | $15.58 | $19.73 | $25.00 | -0.33% |
| Week 4 | $15.00 | $19.71 | $25.90 | -0.44% |
| Week 5 | $14.51 | $19.69 | $26.72 | -0.55% |
| Week 6 | $14.08 | $19.67 | $27.48 | -0.66% |
| Week 7 | $13.69 | $19.65 | $28.20 | -0.77% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Greenwich LifeSciences, Inc. is a clinical-stage biopharmaceutical company that develops novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers in the United States.
Its lead product candidate is GP2, a HER2/neu transmembrane peptide, which is in Phase III clinical trial to prevent breast cancer recurrences in patients.
The company also develops FLAMINGO-01, which is in Phase IIb and 3 Phase I clinical trial designed to evaluate the safety and efficacy of GLSI-100 in HER2 positive breast cancer patients. Greenwich LifeSciences, Inc. was incorporated in 2006 and is headquartered in Stafford, Texas.
GLSI is currently priced at $18.57 per share and has a market capitalization of $272.57M.
The stock sits in the Healthcare category and ranks 3600th. Its current price and market cap place it within a defined market position on the exchange.
Looking ahead, the 2026 forecast shows an average price of $18.57, with a neutral sentiment, and the path to 2030 suggests a rising average price to $33.89, with higher upside in later years. The implied upside increases with time, reaching a 2050 average of $105.79 and a 2050 max of $243.32.
A major floor 40.8% below — a decisive break under it would weaken the trend.
The nearest floor, 7.4% below — buyers have tended to step in here.
The nearest ceiling, 46.4% above — a clean break opens room to run.
A major ceiling 66.8% above — clearing it would confirm fresh momentum.
Key GLSI support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of GLSI market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $19.45 | Buy | $19.88 | Sell |
| MA 10 | $20.95 | Sell | $20.57 | Sell |
| MA 20 | $21.89 | Sell | $21.59 | Sell |
| MA 50 | $23.68 | Sell | $23.03 | Sell |
| MA 100 | $24.47 | Sell | $23.01 | Sell |
| MA 200 | $19.89 | Sell | $20.81 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 41.69 | Neutral |
| Stoch RSI (14) | 54.33 | Neutral |
| CCI (20) | -76.50 | Neutral |
| Williams %R (14) | -72.88 | Info |
| MACD (12,26,9) | -0.22 | Sell |
| ROC (12) | -14.03 | Sell |
| Bollinger %B (20,2) | 0.24 | Neutral |
| Stochastic %K (14) | 27.12 | Neutral |
| TRIX (15) | -0.62 | Sell |
| Awesome (5,34) | -3.89 | Sell |
| Ultimate (7,14,28) | 29.78 | Buy |
| Momentum (10) | 1.47 | Buy |
| Aroon Osc (25) | -60.00 | Sell |
| Hull MA (9) | 18.33 | Buy |
| ADX (14) | 14.74 | Neutral |
| ATR (14) | 1.06 | Info |
The 30-day technical picture is NEUTRAL, with RSI14 at 40.
SMA50 is $23.94 and SMA200 is $19.78, providing nearby moving average context against the current price of $18.57. Support is cited at $18.33 and resistance at $29.23, framing a modest near-term range.
The 30-day range spans $12.85 to $26.84, and annualized volatility is 100%, indicating meaningful but contained near-term price movement within the technical framework.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $18.33 | $19.80 | $28.37 | 0% | Neutral | |
| $20.20 | $27.65 | $40.90 | +40% | Bullish | |
| $23.68 | $34.37 | $54.09 | +74% | Bullish | |
| $22.70 | $34.62 | $57.13 | +75% | Bullish | |
| $22.79 | $36.36 | $62.40 | +84% | Bullish | |
| $20.78 | $34.58 | $61.39 | +75% | Bullish | |
| $19.73 | $34.17 | $62.51 | +73% | Bullish | |
| $22.46 | $40.43 | $75.96 | +104% | Bullish | |
| $26.70 | $49.89 | $96.07 | +152% | Bullish | |
| $31.18 | $60.44 | $119.03 | +205% | Bullish | |
| $32.24 | $71.65 | $154.79 | +262% | Bullish | |
| $52.98 | $117.74 | $270.80 | +495% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $18.33 | $19.80 | $23.41 | +0.00% |
| August 2026 | $16.33 | $19.74 | $24.83 | -0.32% |
| September 2026 | $15.92 | $19.52 | $25.05 | -1.11% |
| October 2026 | $14.71 | $18.25 | $23.82 | -6.51% |
| November 2026 | $15.21 | $19.05 | $25.21 | +4.38% |
| December 2026 | $16.73 | $21.16 | $28.37 | +11.09% |
Click any year to see its month-by-month GLSI forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, GLSI could reach as high as $28.37, with a base case around $19.80 and support toward $18.33 — roughly 0% from $19.80. Price action looks broadly range-bound.
Expect GLSI to range from $20.20 to $40.90 through 2027. The $27.65 average target implies a +40% move from current prices. That is up +40% on the projected 2026 average. Buyers look set to stay in control over this stretch.
The GLSI price prediction for 2028 points to an average of $34.37 (low $23.68, high $54.09) — a potential gain of +74% on today's $19.80. Momentum favours further upside here.
In 2029, GLSI is projected to trade between $22.70 and $57.13, averaging $34.62 — a potential gain of +75% from today's $19.80. That is up +1% on the projected 2028 average. Buyers look set to stay in control over this stretch.
Greenwich LifeSciences, Inc.'s 2030 outlook centres on $36.36, within a $22.79 to $62.40 range. That is up +5% on the projected 2029 average. That marks a +84% change versus current levels. Momentum favours further upside here.
By 2031, GLSI could reach as high as $61.39, with a base case around $34.58 and support toward $20.78 — roughly +75% from $19.80. Buyers look set to stay in control over this stretch.
Expect GLSI to range from $19.73 to $62.51 through 2032. The $34.17 average target implies a +73% move from current prices. That is -1% versus the projected 2031 average. Momentum favours further upside here.
The GLSI price prediction for 2033 points to an average of $40.43 (low $22.46, high $75.96) — a potential gain of +104% on today's $19.80. Buyers look set to stay in control over this stretch.
In 2034, GLSI is projected to trade between $26.70 and $96.07, averaging $49.89 — a potential gain of +152% from today's $19.80. That is up +23% on the projected 2033 average. Momentum favours further upside here.
Greenwich LifeSciences, Inc.'s 2035 outlook centres on $60.44, within a $31.18 to $119.03 range. That is up +21% on the projected 2034 average. That marks a +205% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, GLSI could reach as high as $154.79, with a base case around $71.65 and support toward $32.24 — roughly +262% from $19.80. Momentum favours further upside here.
Expect GLSI to range from $52.98 to $270.80 through 2050. The $117.74 average target implies a +495% move from current prices. That is up +64% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in GLSI today (≈ 50.505051 GLSI) could be worth
$5,946.33
+$4,946.33 (+495%) by 2050 · US Dollar
Based on the average projected GLSI price of $117.74 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in GLSIwould be worth at today's price.
$1,000 invested in GLSI on Jul 10, 2025 (≈ 89.126558 GLSI) would be worth
$1,764.71
+$764.71 (+76.5%) today · 1.76× · US Dollar
Based on a GLSI entry price of $11.22 vs. today's $19.8.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $22 | $900 | -10.0% |
| 1 month ago | $22.11 | $895.52 | -10.4% |
| 3 months ago | $25.78 | $768.04 | -23.2% |
| 6 months ago | $26.83 | $737.98 | -26.2% |
| 1 year ago | $11.22 | $1,764.71 | +76.5% |
| All time (5.0y) ago | $44.14 | $448.57 | -55.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our GLSI forecast.
Our base-case forecast reaches $40.00 around 2033.
Implied market cap at $40.00: $587.13M
The multi-year forecast is bullish overall, with sentiment labeled BULLISH in most years beyond 2026.
In 2027 the average price is $25.73 with a 38.6% ROI; 2028 shows an average of $32.80 with a 76.6% ROI; 2029 averages $32.68 with a 76% ROI; and 2030 averages $33.89 with an 82.5% ROI. These years reflect a gradually improving outlook after a neutral start in 2026.
The forecast continues with 2031 average $32.27, 2032 $30.98, 2033 $36.52, 2034 $46.46, and 2035 $56.20, all bearing bullish sentiment. By 2040 the average is $65.10 with a 250.6% ROI, and by 2050 the average reaches $105.79 with a 469.7% ROI. The 2050 maximum is $243.32, underscoring substantial upside in the long horizon, though these are estimates, not guarantees.
Tap a question to reveal the answer.
The forecast shows an avg price of $33.89, with a min of $20.94 and a max of $58.83, representing an ROI of 82.5% and a BULLISH sentiment.
Forecasts show bullish sentiment from 2027 onward, with 2027 avg $25.73, 2028 avg $32.80, 2029 avg $32.68, 2030 avg $33.89, 2040 avg $65.10, and 2050 avg $105.79. RoIs rise to 38.6%, 76.6%, 76%, 82.5%, 250.6%, and 469.7%, respectively.
Yes. The max forecast reaches $243.32 in 2050, and the 2050 average is $105.79 (with a 2040 max of $142.93).
$272.57M.
Greenwich LifeSciences, Inc. Community Discussion
0Share your Greenwich LifeSciences, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.